| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:37 UTC |
|---|
| HMDB ID | HMDB0014444 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Penciclovir |
|---|
| Description | Penciclovir is only found in individuals that have used or taken this drug. It is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections. It is a nucleoside analogue which exhibits low toxicity and good selectivity. [Wikipedia ]Penciclovir has in vitro activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). In cells infected with HSV-1 or HSV-2, viral thymidine kinase phosphorylates penciclovir to a monophosphate form. The monophosphate form of the drug is then converted to penciclovir triphosphate by cellular kinases. The intracellular triphosphate of penciclovir is retained in vitro inside HSV-infected cells for 10-20 hours, compared with 0.7-1 hour for acyclovir. in vitro studies show that penciclovir triphosphate selectively inhibits viral DNA polymerase by competing with deoxyguanosine triphosphate. Inhibition of DNA synthesis of virus-infected cells inhibits viral replication. In cells not infected with HSV, DNA synthesis is unaltered. Resistant mutants of HSV can occur from qualitative changes in viral thymidine kinase or DNA polymerase. The most commonly encountered acyclovir-resistant mutants that are deficient in viral thymidine kinase are also resistant to penciclovir. |
|---|
| Structure | NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2 InChI=1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18) |
|---|
| Synonyms | | Value | Source |
|---|
| 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine | ChEBI | | 9-(4-Hydroxy-3-hydroxymethylbut-1-yl)-guanine | ChEBI | | 9-[2-Hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine | ChEBI | | 9-[4-Hydroxy-3-(hydroxymethyl)but-1-yl]guanine | ChEBI | | PCV | ChEBI | | PE2 | ChEBI | | Penciclovirum | ChEBI | | Denavir | Kegg | | Novartis brand OF penciclovir | HMDB | | Penciclovir visfarm | HMDB | | SB-CH Brand OF penciclovir | HMDB | | 9-(4-Hydroxy-3-hydroxymethylbut-1-yl)guanine | HMDB | | Vectavir | HMDB | | Visfarm brand OF penciclovir | HMDB | | Penciclovir, monosodium salt | HMDB | | Penciclovir, monosodium salt, monohydrate | HMDB |
|
|---|
| Chemical Formula | C10H15N5O3 |
|---|
| Average Molecular Weight | 253.2578 |
|---|
| Monoisotopic Molecular Weight | 253.117489371 |
|---|
| IUPAC Name | 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-6,9-dihydro-3H-purin-6-one |
|---|
| Traditional Name | denavir |
|---|
| CAS Registry Number | 39809-25-1 |
|---|
| SMILES | NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2 |
|---|
| InChI Identifier | InChI=1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18) |
|---|
| InChI Key | JNTOCHDNEULJHD-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | Hypoxanthines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 6-oxopurine
- Hypoxanthine
- Aminopyrimidine
- Pyrimidone
- N-substituted imidazole
- Pyrimidine
- Azole
- Imidazole
- Heteroaromatic compound
- Vinylogous amide
- Azacycle
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Alcohol
- Primary amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 275 - 277 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 7.45 g/L | Not Available | | LogP | -1.1 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.83 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.448 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.24 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 182.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 731.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 240.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 54.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 155.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 49.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 293.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 263.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 765.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 584.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 71.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 789.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 177.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 196.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 691.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 307.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 262.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Penciclovir,1TMS,isomer #1 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N)=NC2=O | 2635.5 | Semi standard non polar | 33892256 | | Penciclovir,1TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO)CO)C=N2 | 2780.2 | Semi standard non polar | 33892256 | | Penciclovir,1TMS,isomer #3 | C[Si](C)(C)N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 | 2740.1 | Semi standard non polar | 33892256 | | Penciclovir,2TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N)=NC2=O)CO[Si](C)(C)C | 2553.6 | Semi standard non polar | 33892256 | | Penciclovir,2TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO)CO[Si](C)(C)C)C=N2 | 2610.1 | Semi standard non polar | 33892256 | | Penciclovir,2TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C)C(N)=NC2=O | 2609.0 | Semi standard non polar | 33892256 | | Penciclovir,2TMS,isomer #4 | C[Si](C)(C)N(C1=NC(=O)C2=C([NH]1)N(CCC(CO)CO)C=N2)[Si](C)(C)C | 2674.4 | Semi standard non polar | 33892256 | | Penciclovir,2TMS,isomer #5 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C | 2706.5 | Semi standard non polar | 33892256 | | Penciclovir,3TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO[Si](C)(C)C)CO[Si](C)(C)C)C=N2 | 2559.5 | Semi standard non polar | 33892256 | | Penciclovir,3TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO[Si](C)(C)C)CO[Si](C)(C)C)C=N2 | 2808.8 | Standard non polar | 33892256 | | Penciclovir,3TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO[Si](C)(C)C)CO[Si](C)(C)C)C=N2 | 3693.0 | Standard polar | 33892256 | | Penciclovir,3TMS,isomer #2 | C[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C)C(N)=NC2=O)CO[Si](C)(C)C | 2545.6 | Semi standard non polar | 33892256 | | Penciclovir,3TMS,isomer #2 | C[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C)C(N)=NC2=O)CO[Si](C)(C)C | 2727.0 | Standard non polar | 33892256 | | Penciclovir,3TMS,isomer #2 | C[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C)C(N)=NC2=O)CO[Si](C)(C)C | 3770.0 | Standard polar | 33892256 | | Penciclovir,3TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O | 2573.5 | Semi standard non polar | 33892256 | | Penciclovir,3TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O | 2943.3 | Standard non polar | 33892256 | | Penciclovir,3TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O | 3614.5 | Standard polar | 33892256 | | Penciclovir,3TMS,isomer #4 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO[Si](C)(C)C)C=N2)N1[Si](C)(C)C | 2604.2 | Semi standard non polar | 33892256 | | Penciclovir,3TMS,isomer #4 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO[Si](C)(C)C)C=N2)N1[Si](C)(C)C | 2850.7 | Standard non polar | 33892256 | | Penciclovir,3TMS,isomer #4 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO[Si](C)(C)C)C=N2)N1[Si](C)(C)C | 3653.6 | Standard polar | 33892256 | | Penciclovir,3TMS,isomer #5 | C[Si](C)(C)N(C1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C)[Si](C)(C)C | 2722.8 | Semi standard non polar | 33892256 | | Penciclovir,3TMS,isomer #5 | C[Si](C)(C)N(C1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C)[Si](C)(C)C | 2952.9 | Standard non polar | 33892256 | | Penciclovir,3TMS,isomer #5 | C[Si](C)(C)N(C1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C)[Si](C)(C)C | 3613.1 | Standard polar | 33892256 | | Penciclovir,4TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CO[Si](C)(C)C | 2582.8 | Semi standard non polar | 33892256 | | Penciclovir,4TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CO[Si](C)(C)C | 2900.7 | Standard non polar | 33892256 | | Penciclovir,4TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CO[Si](C)(C)C | 3283.2 | Standard polar | 33892256 | | Penciclovir,4TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO[Si](C)(C)C)CO[Si](C)(C)C)C=N2)N1[Si](C)(C)C | 2598.1 | Semi standard non polar | 33892256 | | Penciclovir,4TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO[Si](C)(C)C)CO[Si](C)(C)C)C=N2)N1[Si](C)(C)C | 2808.0 | Standard non polar | 33892256 | | Penciclovir,4TMS,isomer #2 | C[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO[Si](C)(C)C)CO[Si](C)(C)C)C=N2)N1[Si](C)(C)C | 3321.3 | Standard polar | 33892256 | | Penciclovir,4TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C)C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O | 2668.2 | Semi standard non polar | 33892256 | | Penciclovir,4TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C)C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O | 2956.4 | Standard non polar | 33892256 | | Penciclovir,4TMS,isomer #3 | C[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C)C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O | 3257.1 | Standard polar | 33892256 | | Penciclovir,5TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C)C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CO[Si](C)(C)C | 2670.3 | Semi standard non polar | 33892256 | | Penciclovir,5TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C)C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CO[Si](C)(C)C | 2921.9 | Standard non polar | 33892256 | | Penciclovir,5TMS,isomer #1 | C[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C)C(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)CO[Si](C)(C)C | 2985.1 | Standard polar | 33892256 | | Penciclovir,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N)=NC2=O | 2874.5 | Semi standard non polar | 33892256 | | Penciclovir,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO)CO)C=N2 | 2986.8 | Semi standard non polar | 33892256 | | Penciclovir,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 | 2943.9 | Semi standard non polar | 33892256 | | Penciclovir,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3002.7 | Semi standard non polar | 33892256 | | Penciclovir,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO)CO[Si](C)(C)C(C)(C)C)C=N2 | 3030.8 | Semi standard non polar | 33892256 | | Penciclovir,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N)=NC2=O | 3025.1 | Semi standard non polar | 33892256 | | Penciclovir,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)C2=C([NH]1)N(CCC(CO)CO)C=N2)[Si](C)(C)C(C)(C)C | 3103.8 | Semi standard non polar | 33892256 | | Penciclovir,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C(C)(C)C | 3132.9 | Semi standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C=N2 | 3198.8 | Semi standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C=N2 | 3459.0 | Standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C([NH]1)N(CCC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C=N2 | 3741.2 | Standard polar | 33892256 | | Penciclovir,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3172.4 | Semi standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3388.6 | Standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3792.4 | Standard polar | 33892256 | | Penciclovir,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O | 3183.3 | Semi standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O | 3559.5 | Standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1[NH]C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O | 3645.0 | Standard polar | 33892256 | | Penciclovir,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO[Si](C)(C)C(C)(C)C)C=N2)N1[Si](C)(C)C(C)(C)C | 3204.7 | Semi standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO[Si](C)(C)C(C)(C)C)C=N2)N1[Si](C)(C)C(C)(C)C | 3479.7 | Standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO)CO[Si](C)(C)C(C)(C)C)C=N2)N1[Si](C)(C)C(C)(C)C | 3658.9 | Standard polar | 33892256 | | Penciclovir,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3307.8 | Semi standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3532.4 | Standard non polar | 33892256 | | Penciclovir,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)C2=C(N(CCC(CO)CO)C=N2)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3595.9 | Standard polar | 33892256 | | Penciclovir,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3345.3 | Semi standard non polar | 33892256 | | Penciclovir,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3717.5 | Standard non polar | 33892256 | | Penciclovir,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1[NH]C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3498.7 | Standard polar | 33892256 | | Penciclovir,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C=N2)N1[Si](C)(C)C(C)(C)C | 3361.8 | Semi standard non polar | 33892256 | | Penciclovir,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C=N2)N1[Si](C)(C)C(C)(C)C | 3639.4 | Standard non polar | 33892256 | | Penciclovir,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC(=O)C2=C(N(CCC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C=N2)N1[Si](C)(C)C(C)(C)C | 3521.4 | Standard polar | 33892256 | | Penciclovir,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O | 3403.6 | Semi standard non polar | 33892256 | | Penciclovir,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O | 3714.5 | Standard non polar | 33892256 | | Penciclovir,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O | 3455.6 | Standard polar | 33892256 | | Penciclovir,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3557.5 | Semi standard non polar | 33892256 | | Penciclovir,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3823.4 | Standard non polar | 33892256 | | Penciclovir,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CCN1C=NC2=C1N([Si](C)(C)C(C)(C)C)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)CO[Si](C)(C)C(C)(C)C | 3346.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Penciclovir GC-MS (Non-derivatized) - 70eV, Positive | splash10-024r-4890000000-ed3881f9b07a40fef086 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Penciclovir GC-MS (2 TMS) - 70eV, Positive | splash10-0089-4039000000-39d85efcb22394abeb78 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Penciclovir GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , negative-QTOF | splash10-0udi-0190000000-ed1701b795cb216e6d66 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , negative-QTOF | splash10-0udi-0790000000-212e25de28163f343cac | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , negative-QTOF | splash10-0udi-0910000000-3a8ca3a0b3701c27b51d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , negative-QTOF | splash10-0kai-0900000000-36122e670b73f1113fff | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , negative-QTOF | splash10-053r-1900000000-bceccffce9861527c0c8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , negative-QTOF | splash10-0api-3900000000-2322dab886ffdf508841 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , positive-QTOF | splash10-0udi-0490000000-0e41d127a3f6d343b9d6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , positive-QTOF | splash10-0udi-0920000000-8e58b381a6b3d470746b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , positive-QTOF | splash10-0udi-0900000000-d498bce256e98e4cf88c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , positive-QTOF | splash10-0udi-0900000000-ae0beed2651e1125764f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , positive-QTOF | splash10-0udi-0900000000-19ad8b8788d0275996b5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QFT , positive-QTOF | splash10-0udr-1900000000-5c4ec47a69c82954d428 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QQ , positive-QTOF | splash10-0f79-0390000000-2bec5fbdf1e72aa84bde | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QQ , positive-QTOF | splash10-0uei-1940000000-6e49677068b47b74940f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QQ , positive-QTOF | splash10-0udi-3900000000-cc1f9ce4e3ed563ded5c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QQ , positive-QTOF | splash10-0zfr-8900000000-326741cdbb592bb9d271 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-QQ , positive-QTOF | splash10-0f8c-7900000000-295551b253f3f85729c3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir LC-ESI-IT , positive-QTOF | splash10-0udi-0900000000-44a1abcea55a53906b2a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Penciclovir 10V, Positive-QTOF | splash10-0udi-0980000000-aaaff73f565024ce9cff | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penciclovir 10V, Positive-QTOF | splash10-0udr-0090000000-b771df12ed0fcbbee1ca | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penciclovir 20V, Positive-QTOF | splash10-0udr-1980000000-be68269fbcfeb1eda4f2 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penciclovir 40V, Positive-QTOF | splash10-0udr-4900000000-54f7176cadc1b67a66dc | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penciclovir 10V, Negative-QTOF | splash10-0udi-0090000000-b42cd4e9561cb4baa03a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penciclovir 20V, Negative-QTOF | splash10-0udi-0960000000-012e01c533768b510f86 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penciclovir 40V, Negative-QTOF | splash10-0a4l-4900000000-8dda187de53e2d7eb1fb | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
|---|